|
1
|
Bok GH, Cho WY, Cho JY, et al: Endoscopic
resection of hypopharyngeal squamous cell carcinoma. Clin Endosc.
46:189–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clark JI, Hofmeister C, Choudhury A, et
al: Phase II evaluation of paclitaxel in combination with
carboplatin in advanced head and neck carcinoma. Cancer.
92:2334–2340. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshino T, Hasegawa Y, Takahashi S, et al:
Platinum-based chemotherapy plus cetuximab for the first-line
treatment of Japanese patients with recurrent and/or metastatic
squamous cell carcinoma of the head and neck: results of a phase II
trial. Jpn J Clin Oncol. 43:524–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rodrigues AC, Curi R, Genvigir FD, et al:
The expression of efflux and uptake transporters are regulated by
statins in Caco-2 and HepG2 cells. Acta Pharmacol Sin. 30:956–964.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ludwig H, Khayat D, Giaccone G, et al:
Proteasome inhibition and its clinical prospects in the treatment
of hematologic and solid malignancies. Cancer. 104:1794–1807. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang W and Luo HS: Reversal of
chemoresistance to vincristine in gastric cancer cells by NF-kappaB
inhibitor. Zhonghua Zhong Liu Za Zhi. 27:335–338. 2005.(In
Chinese).
|
|
7
|
Fan XM, Wong BC, Wang WP, et al:
Inhibition of proteasome function induced apoptosis in gastric
cancer. Int J Cancer. 93:481–488. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Westerberg CM, Hägglund H and Nilsson G:
Proteasome inhibition upregulates Bim and induces
caspase-3-dependent apoptosis in human mast cells expressing the
Kit D816V mutation. Cell Death Dis. 3:e4172012. View Article : Google Scholar
|
|
9
|
Ma J, Lu S, Yu L, et al: FaDu cell
characteristics induced by multidrug resistance. Oncol Rep.
26:1189–1195. 2011.PubMed/NCBI
|
|
10
|
Youle RJ and Strasser A: The BCL-2 protein
family: opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen YC, Huang WJ, Hsu JL, et al: A novel
hydroxysuberamide derivative potentiates MG132-mediated anticancer
activity against human hormone refractory prostate cancers - the
role of histone deacetylase and endoplasmic reticulum stress.
Prostate. 73:1270–1280. 2013. View Article : Google Scholar
|
|
12
|
Bravo-Cuellar A, Hernández-Flores G,
Lerma-Díaz JM, et al: Pentoxifylline and the proteasome inhibitor
MG132 induce apoptosis in human leukemia U937 cells through a
decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation
of p65. J Biomed Sci. 20:132013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Sun W, Du B, et al: Therapeutic
effect of MG-132 on diabetic cardiomyopathy is associated with its
suppression of proteasomal activities: roles of Nrf2 and NF-κB. Am
J Physiol Heart Circ Physiol. 304:H567–H578. 2013.PubMed/NCBI
|
|
14
|
da Silva SV, Salama C, Renovato-Martins M,
et al: Increased leptin response and inhibition of apoptosis in
thymocytes of young rats offspring from protein deprived dams
during lactation. PLoS One. 8:e642202013.PubMed/NCBI
|
|
15
|
Kanagasabai R, Krishnamurthy K, Druhan LJ,
et al: Forced expression of heat shock protein 27 (Hsp27) reverses
P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene
expression in Adriamycin-resistant human breast cancer cells. J
Biol Chem. 286:33289–33300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Zhang X, Dantas Machado AC, et al:
Structure of p53 binding to the BAX response element reveals DNA
unwinding and compression to accommodate base-pair insertion.
Nucleic Acids Res. 41:8368–8376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pigneux A, Mahon FX, Moreau-Gaudry F, et
al: Proteasome inhibition specifically sensitizes leukemic cells to
anthracyclin-induced apoptosis through the accumulation of Bim and
Bax proapoptotic proteins. Cancer Biol Ther. 6:603–611. 2007.
View Article : Google Scholar
|
